Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

HeartSciences (HSCS) Shares Issued (2022 - 2025)

HeartSciences filings provide 4 years of Shares Issued readings, the most recent being $171276.0 for Q2 2025.

On a quarterly basis, Shares Issued fell 62.04% to $171276.0 in Q2 2025 year-over-year; TTM through Jan 2026 was $543832.0, a 61.9% decrease, with the full-year FY2025 number at $1.1 million, down 88.86% from a year prior.
Shares Issued hit $171276.0 in Q2 2025 for HeartSciences, down from $251436.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $5.2 million in Q4 2022 to a low of -$5.2 million in Q1 2023.
Median Shares Issued over the past 4 years was $265690.0 (2023), compared with a mean of $228790.4.
The widest YoY moves for Shares Issued: up 2172.17% in 2023, down 94.59% in 2023.
HeartSciences' Shares Issued stood at $5.2 million in 2022, then plummeted by 94.59% to $279944.0 in 2023, then plummeted by 56.73% to $121120.0 in 2024, then surged by 41.41% to $171276.0 in 2025.
The last three reported values for Shares Issued were $171276.0 (Q2 2025), $251436.0 (Q1 2025), and $121120.0 (Q4 2024) per Business Quant data.